U.S. Injectable Compounding Pharmacy Market Major Challenges Being Faced by Companies and Their Strategies to Counter Those, Players Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy

Market Overview:

Injectable compounding pharmacy, also known as Injection Pharmacy, is the process of mixing and preparing medication in a container that holds an adequate amount of medicine. This process is done with the help of machines called ‘syringes’ or ‘pipes’ that carry the medication through a process of mixing, conditioning, and freezing. The pharmaceutical industry is witnessing explosive growth due to a number of factors, including the aging U.S. population and the rise of chronic conditions. As the baby boomer generation retires, the demand for products with high therapeutic values will increase. As the health care and pharmaceutical industries expand to meet this demand, several new applications for injectable medication are expected to come up.

Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4478

Competitive Landscape:

Admixture Pharmacy Services, Inc., QuVa Pharma, Nephron Pharmaceuticals Corporation, Olympia Pharmacy, ASP Cares, Athenex, Inc., Fagron Compounding Pharmacies, Avella Specialty Pharmacy, Atlas Pharmaceuticals, Carie Boyd’S Prescription Shop, Empower Pharmacy, Edge Pharma, Imprimis NJOF, LLC, IntegraDose Compounding Services, LLC, Wells Pharma of Houston, LLC, US Compounding Inc., SCA Pharma, and Vertisis Custom Pharmacy.

Key Market Drivers:

Growing prevalence of chronic disease such as cancer and diabetes is propelling growth of the U.S. injectable compounding pharmacy market. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. More and more people are living with not just one chronic illness, such as diabetes, heart disease or depression. Almost a third of the population is now living with multiple chronic conditions.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4478

An increasing aging population group that is highly susceptible to chronic disease is again augmenting growth of the market. According to U.S. Census Bureau, there were 40.3M U.S. residents 65 years and older in the 2010 Census and 54.1M in the July 1, 2019, population estimates.

Covid-19 Impact Analysis 

The coronavirus pandemic has put healthcare & pharma industry under lot of stress, while healthcare sector crawl to do their job in addressing the need. There was high demand for pain management medicine during a pandemic. The industry has witnessed positive growth owing to the growing need for various drugs and device to treat Covid-19 and other chronic diseases.

Key Takeaways:

1. The U.S. injectable compounding pharmacy market is expected to exhibit a CAGR of 7.3 % over the forecast period, owing to growing advancements in science & technology, pharmaceuticals, medical practice, and other interventions in the country.
2. Key players are focusing on adopting partnership and collaboration in the market to expand their product portfolio. For instance, in September 2019, QuVa Pharma, Inc. announced the completion of the next phase of capacity expansion at its Bloomsbury, New Jersey, state-of-the-art cGMP compliant 503B FDA registered manufacturing facility. This is in addition to ongoing investments for further capacity growth at QuVa’s two-scale Texas-based 503B pharmaceutical facilities.

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4478

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Molecule
     • Market Snippet, By Packaging Type
     • Market Snippet, By Pharmacy Type
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
     • Regulatory Aspects Surrounding 503A, and 503B Pharmacies
     • Regulatory Violations by Pharmacies
     • FDA Standing on Regulatory Violations
     • Health Concerns and Warning Letters Sent by FDA to 503B Pharmacies
   • PEST Analysis
   • Epidemiology
   • Market Trends
   • Recent Product Launch
   • Key Primary Insights On 503B Pharmacies
4. U.S. Injectable Compounding Pharmacy Market – Impact of Coronavirus (Covid-19) Pandemic
   
   • During Covid-19 Market Analysis
   • Overall Impact
   • Key Developments
5. U.S. Injectable Compounding Pharmacy Market, By Molecule, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Acetaminophen
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Phenylephrine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Midazolam
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Esmolol
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Vancomycin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Epinephrine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Adenocaine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Fentanyl / Bupivacaine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Morphine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Amiodarone
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Fentanyl
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Heparin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Ketamine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Dextrose
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Hydromorphone
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Bupivacaine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Lidocaine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • BKK (Bupivacaine, Ketorolac, Ketamine)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • RCK (Ropivacaine, Clonidine, Ketorolac)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • RKK (Ropivacaine, Ketorolac, Ketamine)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Norepinephrine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Diltiazem
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Vasopressin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Other Molecules
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
6. U.S. Injectable Compounding Pharmacy Market, By Packaging Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • Vials
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Ampoules
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Prefilled Syringes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
7. U.S. Injectable Compounding Pharmacy Market, By Pharmacy Type, 2017 – 2028, (US$ Mn)
   • Introduction
     • Market Share Analysis, 2021 and 2028 (%)
     • Y-o-Y Growth Analysis, 2018 – 2028
     • Segment Trends
   • 503A Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
   • 503B Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837